60% Growth in Sales for DPPC in September 2025

🔹DPPC, a subsidiary of Tamin Pharmaceutical Investment Company (TPICO), recorded an outstanding performance in September 2025. The company’s sales reached 1,597 billion IRR during the month, marking a 60% increase compared to the 1,000 billion IRR reported in the same period last year.